Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study

Table 6

Receiver operating characteristic curve analysis of adropin, irisin, osteopontin, miR-146a, and miR-144 for predicting diabetes complications in moderate glycemic controlled type 2 diabetes (>7-8% HbA1c, ).

Variable	AUC	SE	CI (95%)	value	Sensitivity	Specificity
miR-146a	0.81	0.47	0.72-0.98	0.001	91.5%	89.4%
miR-144	0.78	0.51	0.69-0.86	0.01	84.7%	86.8%
Adropin	0.82	0.46	0.73-0.93	0.001	79.1%	71.6%
Irisin	0.78	0.43	0.65-0.89	0.01	76.2%	72.3%
Osteopontin	0.91	0.42	0.75-0.95	0.001	88.6%	75.1%

AUC: area under the curve; SE: standard error; CI: confidence interval.